| Literature DB >> 31145535 |
Markus Denzinger1, Manuel Held1, Hanna Scheffler1,2, Hanna Haag3, Andreas K Nussler2, Hans Peter Wendel3, Christian Schlensak3, Adrien Daigeler1, Stefanie Krajewski3.
Abstract
A variety of wound dressing are available for burns. Furthermore, although their impacts on wound healing have been studied sufficiently, their effects on blood remain unclear. Meanwhile, this aspect is extremely important, since blood interacts with the wound dressing, especially in extensive burn injuries. Therefore, the aim of this study is to evaluate the hemocompatibility and immunogenicity of different burn wound dressings. Accordingly, human whole blood (n = 5) was anticoagulated with heparin, treated with different wound dressings and incubated at 37°C for 30 minutes. Different parameters for coagulation and hemocompatibility were evaluated before and after incubation. Consequently, Jelonet, Xenoderm, and Matriderm showed higher TAT-III concentrations, Jelonet, Xenoderm, EZ Derm, and Matriderm were higher β-thromboglobulin; EZ Derm and Burntec showed higher SC5b-9 concentrations after incubation with whole blood. Our ex vivo study provided initial insights into the hemocompatibility and immunogenicity of different burn wound dressings. Moreover, Xenografts (Xenoderm and EZ Derm), Jelonet and Matriderm showed a hemostyptic effect, while EZ Derm and Burntec activated the complement system. Therefore, further studies must be conducted to analyze the possible effects in vivo.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31145535 DOI: 10.1111/wrr.12739
Source DB: PubMed Journal: Wound Repair Regen ISSN: 1067-1927 Impact factor: 3.617